| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |